Get the Stockscreener App
10.56
0.96%
0.10
After Hours:
10.56
Forte Biosciences Inc stock is traded at $10.56, with a volume of 42,025.
It is up +0.96% in the last 24 hours and down -1.86% over the past month.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
See More
Previous Close:
$10.46
Open:
$10.67
24h Volume:
42,025
Relative Volume:
0.43
Market Cap:
$131.29M
Revenue:
-
Net Income/Loss:
$-31.48M
P/E Ratio:
-10.15
EPS:
-1.04
Net Cash Flow:
$-28.71M
1W Performance:
-6.22%
1M Performance:
-1.86%
6M Performance:
+81.44%
1Y Performance:
+50.64%
1-Day Range:
$10.11
$10.70
1-Week Range:
$10.11
$11.50
52-Week Range:
$4.11
$28.68
Forte Biosciences Inc Stock (FBRX) Company Profile
Name
Forte Biosciences Inc
Sector
Industry
Phone
(310) 618-6994
Address
3060 PEGASUS PARK DRIVE, DALLAS, CA
Compare FBRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
10.56 | 135.39M | 0 | -31.48M | -28.71M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-25 | Initiated | Guggenheim | Buy |
| Jan-21-25 | Initiated | TD Cowen | Buy |
| Apr-08-24 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Sep-20-21 | Upgrade | Chardan Capital Markets | Sell → Buy |
| Sep-03-21 | Downgrade | B. Riley Securities | Buy → Neutral |
| Sep-03-21 | Downgrade | Chardan Capital Markets | Buy → Sell |
| Sep-03-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-03-21 | Downgrade | Truist | Buy → Hold |
| May-14-21 | Initiated | B. Riley Securities | Buy |
| Mar-26-21 | Initiated | Citigroup | Buy |
| Aug-28-20 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Aug-25-20 | Initiated | Truist | Buy |
View All
Forte Biosciences Inc Stock (FBRX) Latest News
Quantitative breakdown of Forte Biosciences Inc. recent moveEarnings Recap Summary & Community Supported Trade Ideas - Newser
What high frequency data says about Forte Biosciences Inc.July 2025 Macro Moves & Verified Entry Point Signals - Newser
What’s next for Forte Biosciences Inc. stock priceInsider Buying & Reliable Momentum Entry Alerts - Newser
Is Forte Biosciences Inc. stock bottoming outMarket Trend Summary & Verified Swing Trading Watchlists - Newser
Real time scanner hits for Forte Biosciences Inc. explainedTrade Volume Report & Verified Entry Point Signals - Newser
Is this a good reentry point in Forte Biosciences Inc.Market Growth Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Has Forte Biosciences Inc. found a price floor2025 Earnings Impact & Free Long-Term Investment Growth Plans - Newser
Is it time to cut losses on Forte Biosciences Inc.Earnings Recap Summary & AI Driven Stock Movement Reports - Newser
Real time pattern detection on Forte Biosciences Inc. stockWeekly Investment Report & Weekly Hot Stock Watchlists - Newser
How to recover losses in Forte Biosciences Inc. stockJuly 2025 Rallies & Technical Analysis for Trade Confirmation - Newser
Will Forte Biosciences Inc. bounce back from current supportQuarterly Trade Report & Weekly Momentum Picks - Newser
Applying big data sentiment scoring on Forte Biosciences Inc.CPI Data & Weekly Return Optimization Plans - Newser
Forte Biosciences Inc.’s volatility index tracking explained2025 Momentum Check & Daily Stock Momentum Reports - Newser
How moving averages guide Forte Biosciences Inc. tradingEarnings Overview Summary & Consistent Growth Stock Picks - Newser
Using R and stats models for Forte Biosciences Inc. forecasting2025 Major Catalysts & Smart Money Movement Alerts - Newser
Will Forte Biosciences Inc. stock go up soonJuly 2025 Trends & Weekly Market Pulse Alerts - Newser
Will breakout in Forte Biosciences Inc. lead to full recovery2025 Price Action Summary & Detailed Earnings Play Alerts - Newser
Regression analysis insights on Forte Biosciences Inc. performanceMarket Risk Analysis & High Return Stock Watch Alerts - Newser
Chart overlay techniques for tracking Forte Biosciences Inc.July 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - Newser
Short Interest in Forte Biosciences, Inc. (NASDAQ:FBRX) Declines By 21.2% - MarketBeat
We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash Wisely - Yahoo Finance
Fred Alger Management LLC Reduces Holdings in Forte Biosciences, Inc. $FBRX - MarketBeat
Forte Biosciences Inc. stock trend forecastJuly 2025 EndofMonth & Reliable Volume Spike Trade Alerts - Newser
Can trapped investors hope for a rebound in Forte Biosciences Inc.Market Performance Summary & Fast Entry Momentum Alerts - Newser
Intraday pattern recognizer results for Forte Biosciences Inc. - Newser
Long term hold vs stop loss in Forte Biosciences Inc.Rate Cut & Verified Momentum Stock Ideas - Newser
Is Forte Biosciences Inc. showing signs of accumulationAnalyst Upgrade & Risk Controlled Daily Trade Plans - Newser
Candlestick signals on Forte Biosciences Inc. stock todayJuly 2025 Institutional & Scalable Portfolio Growth Methods - Newser
Forte Biosciences Inc Stock (FBRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):